AESKULISA CARDIOLIPIN AGM— 510(k) K040463

Substantially Equivalent

Aesku, Inc.

FDA 510(k) clearance K040463 for AESKULISA CARDIOLIPIN AGM, Substantially Equivalent on 2004-05-12. Applicant: Aesku, Inc..

Clearance details

Applicant: Aesku, Inc.
Product code: Code MID
Advisory panel: Immunology
Date received: 2004-02-23
Decision date: 2004-05-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.